SciClone Pharmaceuticals’ Vaborem IND Filing Accepted by NMPA
SciClone Pharmaceuticals Inc (HKG: 6600) has announced that an Investigational New Drug (IND) filing for...
Company
Luye Pharma’s Paliperidone Palmitate Accepted for NMPA Review
China-based Luye Pharma Group (HKG: 2186) has announced that the market filing for its paliperidone...
Carrier Biomed Raises ‘Tens of Millions’ in Series A+ Financing Round
Carrier Biomed (Soohow) Co., Ltd, an exosome technology developer based in Suzhou, has reportedly raised...
Everest Medicines Launches First Phase of Global mRNA Vaccine Manufacturing Site
China-based Everest Medicines (HKG: 1952) has announced the initiation of the operation of the first...
InnoCare Pharma Receives Hong Kong Approval for Tafasitamab in DLBCL
China-based biopharma InnoCare Pharma (HKG: 9969, SHA: 688428) has announced receiving market approval from the...
LeadArt Biotechnologies Raises USD 6 Million in Pre-Series A Round
LeadArt Biotechnologies Inc., a chemical proteomics specialist based in Ningbo, has reportedly raised close to...
Simcere Receives NMPA Clearance for SIM0237 Clinical Study
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced receiving clearance from the National Medical Products...
CStone Pharmaceuticals Publishes Ayvakit Study Results on Oncologist Website
China-based CStone Pharmaceuticals (HKG: 2616) has published the results of the China-based bridging NAVIGATOR study...
Biosion Completes Series B Financing Round Led by Guangfa Xinde Investment
Biosion, a global, clinical-stage biotech committed to developing antibody-based therapies targeting immune and oncologic diseases,...
BGI Genomics Receives ANVISA Approval for Colorectal Cancer Detection Kit
China-based genomics giant BGI Genomics Co., Ltd (SHE: 300676) has reported receiving product approval from...
InflaRx and Staidson Amend Deal to Advance Vilobelimab Regulatory Filing in China
Germany-based biopharma InflaRx N.V. (Nasdaq: IFRX) has revealed an amendment to its underlying deal with...
Elpiscience Receives IND Approval for ES014 in China
Shanghai-based Elpiscience Biopharmaceuticals Inc. has announced receiving Investigational New Drug (IND) approval in China to...
Ablaze Pharma and Yonghe Partner for Targeted Radiotherapy Development
China-based Ablaze Pharma and Yonghe Pharmaceutical have struck a partnership agreement for the research and...
InnoCare Pharma’s Orelabrutinib Placed on Partial Clinical Hold by FDA
China-based InnoCare Pharma (HKG: 9969, SHA: 688428) has announced that the US FDA has placed...
Hainan Poly Pharm Receives FDA Approval for Generic Lincomycin
China-based Hainan Poly Pharm Co., Ltd (SHE: 300630) has announced receiving marketing approval from the...
Innovent Biologics’ GFH925 Receives Breakthrough Therapy Designation
China’s Center for Drug Evaluation (CDE) website indicates that China-based Innovent Biologics (HKG: 1801) has...
Junshi Biosciences’ PD-1 Inhibitor Tuoyi Faces FDA Review Delay
Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has announced that they have not received...
Huadong Medicine’s Lanluma V and X Approved for Use in Hainan
China-based Huadong Medicine Co., Ltd (SHE: 000963) has announced receiving approval from the Hainan Medical...
Antengene and MSD Collaborate on Global Clinical Study for ATG-037
China-based Antengene Corporation Limited (HKG: 6996) has announced a global clinical collaboration with Merck, Sharp...
IASO Biotherapeutics Receives FDA Approval for CT103A IND Application
China-based IASO Biotherapeutics has announced approval from the US FDA for an Investigational New Drug...